v1
An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy.
- NobleID
- NI7P41W84R09S47
- Persistent link
- https://nobleid.org/ark:/48914/w1/20260515/FFD4DA33
Type:Journal Article
0 views
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims